| First Author | Liu Z | Year | 2015 |
| Journal | J Biol Chem | Volume | 290 |
| Issue | 4 | Pages | 2312-20 |
| PubMed ID | 25451940 | Mgi Jnum | J:218380 |
| Mgi Id | MGI:5617404 | Doi | 10.1074/jbc.M114.616441 |
| Citation | Liu Z, et al. (2015) Liver Kinase B1 Suppresses Lipopolysaccharide-induced Nuclear Factor kappaB (NF-kappaB) Activation in Macrophages. J Biol Chem 290(4):2312-20 |
| abstractText | Liver kinase B1 (LKB1), a serine/threonine kinase, is a tumor suppressor and metabolic regulator. Recent data suggest that LKB1 is essential in regulating homeostasis of hematopoietic cells and immune responses. However, its role in macrophages and innate immune system remains unclear. Here we report that macrophage LKB1 inhibits pro-inflammatory signaling in response to LPS. LPS-induced pro-inflammatory cytokines and pro-inflammatory enzymes were monitored in bone marrow-derived macrophages isolated from myeloid cell-specific LKB1 knock out mice and their wild type littermate control mice. LPS induced higher levels of pro-inflammatory cytokines and pro-inflammatory enzymes in bone marrow-derived macrophages from LKB1 KO than those from wild type mice. Consistently, LPS induced higher levels of NF-kappaB activation in LKB1-deficient macrophages than those in wild type. Further, LPS stimulation significantly increased LKB1 phosphorylation at serine 428, which promoted its binding to IkappaB kinasebeta (IKKbeta), resulting in the inhibition of NF-kappaB. Finally, LPS injection caused higher levels of cytokine release and more severe tissue injury in the lung tissues of LKB1 KO mice than in those of control mice. We conclude that LKB1 inhibits LPS-induced NF-kappaB activation in macrophages. |
